Novo stock: Price targets keep falling:
Novo Nordisk disappoints at its capital markets day: Analysts lower price targets.
deraktionaer.de/artikel/pharma-biotech/novo-aktie-kursziele-fallen-immer-weiter-20409286.html
Story Details
| Last Updated | |
| Total Articles | 1 |
Main Topics
single unit of ownership in a corporation, mutual fund, or any other organization
Similar to This
Previous
Novo Nordisk: Three important dates ahead!: Eli Lilly reaches an all-time high, while Novo Nordisk awaits key November dates, including its quarterly report and ...
deraktionaer.de/artikel/pharma-biotech/novo-nordisk-drei-wichtige-termine-voraus-20429702.html
Eli Lilly shoots to a new record high according to figures - | and leaves Novo in the dust
deraktionaer.de/artikel/pharma-biotech/eli-lilly-schiesst-nach-zahlen-auf-ein-neues-rekordhoch-und-zeigt-novo-die-ruecklichter-20428193.html
Lilly is worth 6 times as much as Novo: Will the gap now widen even further?: Novo Nordisk fails with an emergency application against Lilly's advertising ...
wallstreet-online.de/nachricht/21588504-klatsche-gericht-lilly-6-mal-wert-novo-abstand-groesser
Walmart offensive: Why Novo and Eli Lilly also benefit: Walmart erweitert 2027 die Krankenversicherung: Über 250 Medikamente sind ohne Zuzahlung erhältlich ...
deraktionaer.de/artikel/pharma-biotech/walmart-offensive-warum-auch-novo-und-eli-lilly-profitieren-20416625.html
Novo stock before the test: Next price target scrapped: BMO Capital lowers its price target for Novo Nordisk to $40 as Ozempic sales in the US come under ...
deraktionaer.de/artikel/pharma-biotech/novo-aktie-vor-dem-test-naechstes-kursziel-kassiert-20415370.html
Between value trap, turnaround and dividend opportunity: What really matters at Novo Nordisk
deraktionaer.de/artikel/pharma-biotech/zwischen-value-falle-turnaround-und-dividenden-chance-was-bei-novo-nordisk-wirklich-zaehlt-20414131.html
Novo: Things are happening fast: Novo secures almost all global rights to HRS-1596 from Hengrui Pharma.
deraktionaer.de/artikel/pharma-biotech/novo-es-geht-schlag-auf-schlag-20409703.html
Novo share price at rock bottom - | Licensing deal causes Swedish small cap to explode
deraktionaer.de/artikel/pharma-biotech/novo-aktie-am-boden-lizenzdeal-laesst-schwedischen-small-cap-explodieren-20409567.html
Yields keep rising, Novo's tough week, why cat product sales are surging and more in Morning Squawk
cnbc.com/2026/09/25/5-things-to-know-before-the-stock-market-opens.html
Viking Therapeutics after the share price explosion: Analysts see more than 100 percent potential
deraktionaer.de/artikel/pharma-biotech/viking-therapeutics-nach-der-kursexplosion-analysten-sehen-mehr-als-100-prozent-potenzial-20409316.html
Shareholder tip: Viking Therapeutics explodes - | Novo share reacts: Viking Therapeutics reports positive study data for VK2735, an obesity drug ...
deraktionaer.de/artikel/pharma-biotech/aktionaer-tipp-viking-therapeutics-explodiert-novo-aktie-reagiert-20409272.html
Eli Lilly stock: Weight loss pill Foundayo catches up with Novo, but!: Eli Lilly: Foundayo captures every third new pill prescription
deraktionaer.de/artikel/pharma-biotech/eli-lilly-aktie-abnehmpille-foundayo-holt-gegen-novo-auf-aber--20409245.html
Novomatic stock in free fall: Capital Markets Day causes long faces: The Danes are holding a Capital Markets Day in London to kick off the new trading week.
deraktionaer.de/artikel/pharma-biotech/novo-aktie-im-freien-fall-kapitalmarkttag-sorgt-fuer-lange-gesichter-20409125.html
Weight-loss medications: Eli Lilly soaring, Novo Nordisk in freefall: Novo Nordisk expects a sales decline of up to 6 percent. Competitor Eli Lilly ...
manager-magazin.de/unternehmen/pharma/eli-lilly-us-konzern-im-hoehenflug-novo-nordisk-rechnet-mit-rueckgaengen-a-839421a1-543a-49a2-aec1-d4b8f1e13d41
Obesity battle heats up again as Novo claws way back into race with Lilly: Novo Nordisk investors have found little cause for optimism during a bruising two-year ...
reuters.com/legal/litigation/obesity-battle-heats-up-again-novo-claws-way-back-into-race-with-lilly-2026-08-03/
Stock surges: More than a million Americans are using the new Wegovy weight-loss pill
manager-magazin.de/unternehmen/pharma/novo-nordisk-aktie-mit-kurssprung-ueber-eine-million-nutzer-der-wegovy-abnehmpille-a-2e38aeaa-9b92-4e42-b274-c3b51c83a424
Novo Nordisk stock under pressure: Competition, IPO, pill race, billion-dollar deal: How the situation is changing for Novo Nordisk
finanzen.net/nachricht/aktien/adipositas-markt-novo-nordisk-aktie-unter-druck-wettbewerb-verschaerft-sich-neue-rivalen-neue-pillen-00-15620444
Pfizer tops estimates, raises profit guidance even as sales fall: Pfizer hiked its full-year profit guidance, citing its strong business performance and cost ...
cnbc.com/2025/11/04/pfizer-pfe-earnings-q3-2025.html
Next